Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.
DASSAULT SYSTEMES SA ADR (DASTY) news on Stock Titan reflects the official communications of Dassault Systèmes, a software publisher in the information sector whose underlying shares trade on Euronext Paris as DSY.PA. The company’s releases provide insight into its 3DEXPERIENCE platform, virtual worlds strategy and AI-embedded software offerings, as well as its capital markets activity.
Investors following DASTY can use this page to review earnings and financial updates, where Dassault Systèmes reports quarterly and year-to-date revenue, software revenue, recurring revenue, operating margin and diluted earnings per share under IFRS and non-IFRS measures. These announcements also break down software revenue by geography, product line and industry, and highlight the contribution of areas such as Industrial Innovation, Life Sciences and Mainstream Innovation.
The news feed also includes corporate and strategic announcements, such as information about Medidata, a Dassault Systèmes brand that provides clinical trial solutions. Releases describe Medidata Patient, Data and Study Experiences and collaborations with life sciences companies like Sanofi, emphasizing goals such as streamlining clinical workflows, enhancing data quality and accelerating the development of new therapies.
In addition, Dassault Systèmes publishes regulatory and capital markets disclosures, including declarations of the number of outstanding shares and voting rights, reports on trading in its own shares under repurchase programs, and half-year statements on its liquidity contract. Bookmark this page to access a consolidated view of these official updates related to DASTY and the underlying Dassault Systèmes shares.
Tarek Sherif, co-founder of Medidata and Life Sciences & Healthcare Sector Board Chairman for Dassault Systemes, joins the board of directors at Florence. With over 20 years of experience, including leading Medidata to an IPO and acquiring it for $5.8B, Sherif aims to enhance Florence's position in clinical research. The company, serving over 10,000 trial sites in 44 countries, recently raised $80M in a Series C funding round to improve trial site efficiencies and connectivity in clinical development.
Dassault Systèmes has announced a global employee shareholding program targeting around 98% of its workforce. This capital increase will involve issuing up to 5 million shares on January 20, 2022. Through this initiative, employees will participate more closely in the company's growth and benefit from their contributions. CEO Bernard Charlès emphasized the program's inclusive approach and long-term vision, underscoring the importance of employee investment in the company's journey.
Dassault Systèmes disclosed its trading activity in its own shares for the period from September 30 to October 1, 2021. During this time, a total of 278,513 shares were traded at a weighted average price of €45.6740 on XPAR. Additionally, on October 1, 2021, 354,000 shares were traded at an average price of €44.9420. This trading is in line with the share repurchase program authorized by the General Meeting of Shareholders on May 26, 2021. Detailed information can be accessed on Dassault Systèmes' investor relations website.
Dassault Systèmes has reported the number of outstanding shares and voting rights as of September 30, 2021. The total number of outstanding shares is 1,331,754,937, while the total voting rights amount to 1,992,397,166. This information is in compliance with the regulations set by the Autorité des marchés financiers. Shareholders are advised to refer to Article 223-11 for details on declaring thresholds. For declarations related to crossing thresholds, shareholders can contact the Investors Relations Service of Dassault Systèmes.
Dassault Systèmes SE has disclosed its trading activities for the period from September 24 to September 29, 2021, following the repurchase program approved by shareholders on May 26, 2021. During this time, a total of 1,400,384 shares were repurchased, with daily volumes ranging from 15,890 to 331,346 shares. The average acquisition prices varied each day, with the lowest being approximately 45.91 and the highest at 49.50 per share. Full details about the transactions can be found on their investor relations website.
AllStripes has appointed Sherwin Chen as Chief Legal Officer and Joe Walsh as Vice President, Head of Commercial. These appointments are aimed at supporting the company's growth in rare disease research. Chen brings nearly 20 years of legal expertise from roles at Color Health and Roche, while Walsh has significant experience from Komodo Health. Both leaders will enhance AllStripes' efforts to empower the rare disease community and expand partnerships within the life sciences sector.
Dassault Systèmes disclosed the trading activities for its own shares from September 16 to September 22, 2021, as part of the repurchase program approved by shareholders on May 26, 2021. During this period, the company reported numerous transactions across various markets, including XPAR and DXE. The total volume of shares traded varied daily with acquisition prices averaging approximately €49.49. Detailed information on these transactions is available on the company's investor relations website.
Dassault Systèmes disclosed its share repurchase activities conducted between September 8 and September 15, 2021. The report details daily trading transactions, including the number of shares bought and the average acquisition prices. Noteworthy transactions included the purchase of 242,385 shares at an average price of €49.3991 on September 15, 2021. Investors can find a comprehensive breakdown of these trades on the company's investor relations website.
Nextech AR Solutions Corp (OTCQB: NEXCF) has launched its innovative CAD to POLY solution, aimed at transforming CAD files into optimized 3D meshes for AR applications. This advancement positions Nextech to capitalize on the $11 billion CAD market. A provisional patent has been filed, enhancing scalability for their ecommerce 3D models. The company plans to offer this CAD to POLY technology as a SaaS product in 2022, which is already in use by select customers. Key players in the CAD market, including Dassault Systemes and Autodesk, have been identified as potential clients.
BIOMEDevice Boston is set to return on September 21-22 at the Boston Convention & Exhibition Center, bringing together the biomedical industry. The event will feature the Startup Stadium, in partnership with the Massachusetts Medical Device Industry Council (MassMEDIC), showcasing emerging medical technology companies. Attendees can expect a full day of educational content, including insights into the medtech investment landscape. With over $100 million in VC funding noted in the life sciences sector, the event highlights the increasing importance of education in navigating this robust investment.